Skip to main content

and
  1. No Access

    Article

    Longitudinal serum neurofilament light chain (sNfL) concentration relates to cognitive function in multiple sclerosis patients

    Serum neurofilament light chain (sNfL) may be used as a biological marker of disease progression in multiple sclerosis (MS), although longitudinal studies correlating cognitive deficits to sNfL are limited.

    Flavia Mattioli, F. Bellomi, C. Stampatori, S. Mariotto, S. Ferrari in Journal of Neurology (2020)

  2. No Access

    Article

    Dealing with highly active multiple sclerosis after natalizumab-associated PML: could rituximab be of help?

    Chiara Rosa Mancinelli, C. Scarpazza, G. Santuccio, N. De Rossi in Neurological Sciences (2018)

  3. No Access

    Article

    Use of herbal remedies by multiple sclerosis patients: a nation-wide survey in Italy

    Though recent progress in multiple sclerosis (MS) treatment is remarkable, numerous unmet needs remain to be addressed often inducing patients to look for complementary and alternative medicines (CAM), especia...

    A. Loraschi, P. Bellantonio, F. Bortolon, R. Capra, P. Cavalla in Neurological Sciences (2016)

  4. Article

    Open Access

    The Physics of the B Factories

    A. J. Bevan, B. Golob, Th. Mannel, S. Prell in The European Physical Journal C (2014)

  5. No Access

    Article

    Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group—Italian Neurological Society

    Three years after the introduction of natalizumab (NA) therapy for the second line treatment of relapsing-remitting multiple sclerosis (MS), Italian MS centers critically reviewed the scientific literature and...

    A. Ghezzi, L. M. E. Grimaldi, M. G. Marrosu, C. Pozzilli, G. Comi in Neurological Sciences (2011)

  6. No Access

    Article

    The effect of natalizumab on cognitive function in patients with relapsing-remitting multiple sclerosis: preliminary results of a 1-year follow-up study

    The objective of the study was to assess the natalizumab effect on the course of cognitive impairment in patients with relapsing-remitting multiple sclerosis (MS). Patients with active relapsing-remitting MS (n =...

    Flavia Mattioli, C. Stampatori, R. Capra in Neurological Sciences (2011)

  7. No Access

    Article

    Natalizumab efficacy on cognitive impairment in MS

    We report follow-up data on the efficacy of natalizumab therapy on neuropsychological impairment on an italian MS group of 39 patients at 1 year and of 11 patients at 2 years. Results show a significant reduct...

    F. Mattioli, C. Stampatori, F. Bellomi, R. Capra in Neurological Sciences (2011)

  8. No Access

    Article

    Neuropsychological rehabilitation in adult multiple sclerosis

    Neuropsychological impairment affects 40–65% of multiple sclerosis patients, mainly involving speed in information processing, attention, executive functions and memory. Deterioration occurs over time independ...

    F. Mattioli, C. Stampatori, F. Bellomi, R. Capra, M. Rocca in Neurological Sciences (2010)

  9. No Access

    Article

    Progranulin gene variability increases the risk for primary progressive multiple sclerosis in males

    Progranulin (GRN) gene variability has been analyzed in a sample of 354 patients with multiple sclerosis (MS) compared with 343 controls. No significant differences were observed, but by stratifying according to ...

    C Fenoglio, D Scalabrini, F Esposito, C Comi, P Cavalla, M De Riz in Genes & Immunity (2010)

  10. No Access

    Article

    Ataxia with isolated vitamin E deficiency: neurological phenotype, clinical follow-up and novel mutations in TTPAgene in Italian families

    Ataxia with vitamin E deficiency (AVED) is a rare autosomal recessive neurodegenerative disorder due to mutations in the alpha-tocopherol transfer protein (TTPA) gene on chromosome 8q13. AVED patients have progre...

    C. Mariotti, C. Gellera, M. Rimoldi, R. Mineri, G. Uziel, G. Zorzi in Neurological Sciences (2004)

  11. No Access

    Article

    The contribution of fast-FLAIR MRI for lesion detection in the brain of patients with systemic autoimmune diseases

    Fast fluid-attenuated inversion recovery (fFLAIR) is more sensitive that conventional or fast spin echo T2-weighted magnetic resonance imaging (MRI) for detecting lesions in the brain of patients with ischemi...

    M. Rovaris, M. Inglese, B. Viti, G. Ciboddo, S. Gerevini, R. Capra in Journal of Neurology (2000)

  12. No Access

    Article

    Disease activity in multiple sclerosis studied by weekly triple-dose magnetic resonance imaging

    This study assessed whether dysfunction of the blood-brain barrier is an obligatory early event in lesion formation in multiple sclerosis. Dual-echo and T1-weighted magnetic resonance imaging after the inject...

    C. Tortorella, M. Codella, M. A. Rocca, C. Gasperini, R. Capra in Journal of Neurology (1999)

  13. No Access

    Article

    Two sisters with multiple sclerosis, lamellar ichthyosis, beta thalassaemia minor and a deficiency of factor VIII

    Two of four sisters have multiple sclerosis (MS), lamellar ichthyosis, beta thalassaemia minor and a quantitative deficit of factor VIII-von Willebrand complex. The mother and the other sisters have only beta ...

    R. Capra, F. Mattiolil, B. Kalman, N. Marcianò, A. Berenzi in Journal of Neurology (1993)

  14. No Access

    Article

    Neuropsychological assessment in multiple sclerosis: a follow-up study with magnetic resonance imaging

    Nineteen moderately impaired patients with clinically definite multiple sclerosis and an initially relapsing-remitting course were included in a neuropsychological and magnetic resonance imaging (MRI) follow-u...

    C. Mariani, E. Farina, S. F. Cappa, G. P. Anzola, L. Faglia in Journal of Neurology (1991)

  15. No Access

    Article

    Failure to find HTLV I and HIV I serum antibodies in MS patients

    R. Capra, F. Mattioli, N. Manca, G. Scura in The Italian Journal of Neurological Sciences (1988)

  16. No Access

    Article

    Myasthenic crisis during intravenous iodinated contrast medium injection

    G. P. Anzola, R. Capra, M. Magoni in The Italian Journal of Neurological Scienc… (1986)